Machina Capital S.A.S. Takes Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Machina Capital S.A.S. acquired a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 9,787 shares of the company's stock, valued at approximately $765,000.

Several other institutional investors also recently bought and sold shares of the company. State Street Corp boosted its stake in GE HealthCare Technologies by 7.8% in the third quarter. State Street Corp now owns 18,615,890 shares of the company's stock valued at $1,747,101,000 after acquiring an additional 1,347,114 shares in the last quarter. Geode Capital Management LLC boosted its stake in GE HealthCare Technologies by 7.2% in the third quarter. Geode Capital Management LLC now owns 10,977,757 shares of the company's stock valued at $1,026,898,000 after acquiring an additional 733,819 shares in the last quarter. Van ECK Associates Corp boosted its stake in GE HealthCare Technologies by 107.3% in the fourth quarter. Van ECK Associates Corp now owns 4,841,652 shares of the company's stock valued at $378,520,000 after acquiring an additional 2,506,417 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in GE HealthCare Technologies by 11.2% in the fourth quarter. Bank of New York Mellon Corp now owns 3,476,586 shares of the company's stock valued at $271,800,000 after acquiring an additional 349,539 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in GE HealthCare Technologies by 9.2% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,959,256 shares of the company's stock valued at $231,355,000 after acquiring an additional 248,318 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock traded up $1.17 during trading on Friday, hitting $86.58. 4,075,712 shares of the company's stock were exchanged, compared to its average volume of 2,984,066. GE HealthCare Technologies Inc. has a 52-week low of $74.51 and a 52-week high of $94.80. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The business has a 50-day simple moving average of $86.77 and a 200-day simple moving average of $86.16. The stock has a market capitalization of $39.59 billion, a price-to-earnings ratio of 20.00, a PEG ratio of 3.19 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating analysts' consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The company had revenue of $5.32 billion during the quarter, compared to analysts' expectations of $5.33 billion. On average, research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

Analyst Ratings Changes

A number of research analysts have issued reports on GEHC shares. Wells Fargo & Company raised their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a report on Friday, February 14th. Citigroup raised their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a report on Thursday, February 13th. Finally, Jefferies Financial Group raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and raised their price target for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. One analyst has rated the stock with a sell rating, three have issued a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, GE HealthCare Technologies currently has a consensus rating of "Moderate Buy" and a consensus price target of $97.67.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.